Zusammenfassung
Die zunehmende Verbreitung der Neuroleptika, die Ausweitung ihres Indika tionsspektrums, neuere Erkenntnisse über Begleitwirkungen und die verstärkte Sensibilität von Patienten und Angehörigen gegenüber medikamentösen Nebenwirkungen machen es notwendig, Nutzen und Risiken der Langzeitbehandlung mit Neuroleptika kritisch gegeneinander abzuwägen (Gardos u. Cole 1976; Helmchen 1978; Davis et al. 1980; Gottfries 1981; Hippius u. Klein 1983; Kane 1984; Johnson 1985; Tegeler 1987).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alexopoulos GS (1979) Lack of complaints in schizophrenics with tardive dyskinesia. J Nerv Ment Dis 167:125–127
Andreasen NC (1981) Scale for the Assessment of Negative Symptoms (SANS). The Univer sity of Iowa, Iowa City
Baldessarini RJ (1985) Clinical and epidemiologic aspects of tardive dyskinesia. J Clin Psychiatry 46:8–13
Barnes TRE, Braude WM (1984) Persistent akathisia associated with early tardive dyskinesia. Postgrad Med J 60:359–361
Barnes TRE, Trauer T (1982) Reliability and validity of a tardive dyskinesia videotape rating technique. Brit J Psychiatry 140:508–515
Bartels M, Themelis (1983) Computerized tomography in tardive dyskinesia. Arch Psychiatr Nervenkr 233:371–379
Bartels M, Riffel D, Stöhr M (1982) Tardive Dystonie: Eine seltene Nebenwirkung nach Neuroleptika-Langzeitbehandlung. Nervenarzt 53:674–676
Bergen JA, Griffiths DA, Rey JM, Beumont JV (1984) Tardive dyskinesia: Fluctuating patient or fluctuating rater. Br J Psychiatry 144:498–502
Branchey MC, Branchey LB, Richardson MA (1981) Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients. Am J Psychiatry 138:608–612
Brücher K (1982) Die Spätdyskinesien -Eine Übersicht über Klinik, Pathogenese, Prophylaxe und Therapie eines späten neuroleptischen Seiteneffekts. Fortschr Neurol Psychiat 50:138–199
Burke RE, Fahn S, Lankowic J (1982) Tardive dystonia: Late onset and persistent dystonia caused by antipsychotic drugs. Neurology 32:1335–1346
Casey DE (1985 a) Spontaneous and tardive dyskinesia: Clinical and laboratory studies. J Clin Psychiatry 46:42–47
Casey DE (1985 b) Tardive dyskinesia: Reversible and irreversible. In: Casey DE, ChaseTN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacol-ogy, Suppl 2. Springer, Berlin Heidelberg New York Tokyo
Casey DE, Chase TN, Christensen AV, Gerlach J (1985) Dyskinesia research and treatment. Psychopharmacology, Suppl 2. Springer, Berlin Heidelberg New York Tokyo
Chiang E, Pitts WM, Rodriguez-Garcia M (1985) Respiratory dyskinesia: Review and case reports. J Clin Psychiatry 46:232–234
Chouinard G, Annable L, Ross-Chouinard A, Nostores JN (1979) Factors related to tardive dyskinesia. Am J Psychiatry 136:79–83
Christensen AV, Greil W, Haag H et al. (1986) Animal models for assessing extrapyramidal-motor side-effects of neuroleptics. Pharmacopsychiatria 19:149–151
Crane G (1968) Tardive dyskinesia in patients treated with major neuroleptics: A review of the literature. Am J Psychiatry 124:40–48
Crane G (1972) Pseudoparkinsonmism and tardive dyskinesia. Arch Neurol 27:426–430
Csernansky JG, Grabowski K, Cervantes J, Kaplan J, Yesavage JA (1981) Fluphenazine decanoate and tardive dyskinesia: A possible association. Am J Psychiatry 138:1362–1365
Davis JM, Schaffer CM, Killian GA, Kinard C, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6:70–87
Davis KL, Berger PA, Hollister LE (1976) Tardive dyskinesia and depressive illness. Psychopharmacol Commun 2:125–130
Degkwitz R, Luxemburger O (1965) Das terminale extrapyramidale Insuffizienz-bzw. De-fektsyndrom infolge chronischer Anwendung von Neuroleptika. Nervenarzt 36:173–175
Degkwitz R, Binsack KF, Herkert H, Luxemburger O, Wenzel W (1966) Zum Problem der terminalen extrapyramidalen Hyperkinesen anhand von 1600 langfristig mit Neuroleptika Behandelten. Arzneimittelforsch 16:276–279
Ekbom K, Lindholm H, Ljundberg L (1972) New dystonic syndrom associated with butyrophenone therapy. J Neurol 202:94–103
Ezrin Waters C, Seeman MV, Seeman P (1981) Tardive dyskinesia in schizophrenic out patients: Prevalence and significant variables. J Clin Psychiatry 42:16–22
Faheem AD, Brightwell DR, Burton GC, Struss A (1982) Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: Tardive dyskinesia? Am J Psychiatry 139:517–518
Fairbairn AF, Rowell FJ, Hui SM, Hassanyeh F, Robinson AJ, Eccleston D (1983) Serum concentration of depot neuroleptics in tardive dyskinesia. Br J Psychiatry 142:579–583
Famuyiwa OO, Eccleston D, Donaldson AA, Garside RF (1979) Tardive dyskinesia and dementia. Br J Psychiatry 135:500–504
Fann WE, Stafford JR, Malone RL, Frost JD, Richman BW (1980) Clinical research techniques in tardive dyskinesia. Am J Psychiatry 134:759–762
Firth WR, Ardern MH (1985) Measuring abnormal movement in tardive dyskinesia: A pilot study. Brit J Psychiatry 147:723–726
Gardos G, Cole JO (1976) Maintenance antipsychotic therapie: Is the cure worse than the disease? Am J Psychiatry 133:32–36
Gardos G, Cole JO (1983) Tardive dyskinesia and anticholinergic drugs. Am J Psychiatry 140:200–202
Gardos G, Cole JO, La Brie R (1977) The assessment of tardive dyskinesia. Arch Gen Psychiatry 34:1206–1212
Gelenberg AJ (1976) Computerized tomography in patients with tardive dyskinesia. Am J Psychiatry 133:578–579
Gerlach J (1975) Pathophysiological mechanism underlying tardive dyskinesia. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacology, Suppl 2. Springer, Berlin Heidelberg New York
Gerlach J (1977) The relationship between parkinsonism and tardive dyskinesia. Am J Psychiatry 134:781–784
Gerlach J (1979) Tardive dyskinesia. Dan Med Bull 26:209–245
Gerlach J, Korsgaard S (1983) Classification of abnormal involuntary movements in psychiatric patients. Neuropsychiatr Clin 2:201–208
Gerlach J, Thorsen K (1976) The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment. Int Pharmacol Psychiatry 11:1–7
Gibson AC (1981) Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection. Acta Psychiat Scand (Suppl 291) 63:111–114
Goldberg SC, Shenoy RS, Julius D, Hamer RM, Ross B, Minton T, Spiro M (1982) Do long-acting injectable neuroleptics protect against tardive dyskinesia? Psychopharmacol Bull 18:177–179
Gottfries CG (1981) Long-term neuroleptic treatment benefits and risks. Acta Psychiat Scand (Suppl 291) 63:75–88
Granacher RP (1981) Differential diagnosis of tardive dyskinesia: An overview. Am J Psychiatry 138:1288–1297
Greil W, Haag H, Rossnagl G, Rüther E (1984) Effect of anticholinergics on tardive dyskinesia. Br J Psychiatry 145:304–310
Haag H, Greil W, Rüther E (1987) Zusammenhang zwischen Spätdyskinesie und verschiedenen Variablen der neuroleptischen Behandlung. In: Heinrich K, Klieser E (Hrsg) Probleme der neuroleptischen Dosierung. Schattauer, Stuttgart
Haddenbrock S (1964) Hyperkinetische Dauersyndrome nach hochdosierter und Langstreckenbehandlung mit Neuroleptika. In: Kranz H, Heinrich K (Hrsg) Begleitwirkungen und Mißerfolge der psychiatrischen Pharmakotherapie. Thieme, Stuttgart
Hansen TE, GlazerWM, Moore DC (1986) Tremor and tardive dyskinesia. J Clin Psychiatry 47:461–464
Heinrich K, Tegeler J (1983) Dyskognitive, apathische und extrapyramidale Syndrome bei Langzeit-Neurolepsie. In: Hippius H, Klein HE (Hrsg) Therapie mit Neuroleptika. Perimed, Erlangen
Heinrich K, Wegener I, Bender HJ (1968) Späte extrapyramidale Hyperkinesen bei neuroleptischer Langzeittherapie. Pharmacopsychiatria 1:169–195
Helmchen H (1978) Forschungsaufgaben bei psychiatrischer Langzeitmedikation. Nervenarzt 49:534–538
Hippius H, Klein HE (1983) Therapie mit Neuroleptika. Perimed, Erlangen
Hippius H, Lange G (1970) Zur Problematik der späten extrapyramidalen Hyperkinesen nach langfristiger neuroleptischer Therapie. Arzneimittelforsch 20:888–889
Jeste DV, Wyatt RJ (1981) Changing epidemiology of tardive dyskinesia: An overview. Am J Psychiatry 138:297–309
Jeste DV, Wyatt RJ (1982) Understanding and treating tardive dyskinesia. Guilford, New York
Jeste DV, Potkin SG, Sindha S, Feder S, Wyatt RJ (1979) Tardive dyskinesia: Reversible and persistent. Arch Gen Psychiatry 36:585–590
Jeste DV, Rosenblatt JE, Wagner RL, Wyatt RJ (1979) High serum neuroleptic levels in tar dive dyskinesia? N Engl J Med 301:1184–1186
Jeste DV, Wagner RL, Weinberger DR, Rieth KJ, Wyatt RJ (1980) Evaluation of CTscans in tardive dyskinesia. Am J Psychiatry 137:247–249
Jeste DV, Karson CN, lager AC, Bigelow LB, Wyatt RJ (1984) Association of abnormal involuntary movements and negative symptoms. Psychopharmacol Bull 20:380–381
Johnson DAW (1985) Antipsychotic medication: Clinical guidelines for maintenance therapy. J Clin Psychiatry 46:6–15
Jus A, Jus K, Fontaine P (1979) Longterm treatment of tardive dyskinesia. J Clin Psychiatry 40:72–77
Kalachnik JE, Young RC, Offerman D (1984) A tardive dyskinesia evaluation and diagnosis form for applied facilities. Psychopharmacol Bull 20:303–307
Kane JM (1984) The use of depot neuroleptics: Clinical experience in the United States. J Clin Psychiatry 45:5–12
Kane JM, Smith JM (1982) Tardive dyskinesia prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39:473–481
Kane JM, Woerner M, Lieberman J (1985) Tardive dyskinesia: Prevalence, incidence and risk factors. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmalogy, Suppl 2. Springer, Berlin Heidelberg New York Tokyo
Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B (1984) Incidence of tardive dyskinesia: Five-year data from a prospective study. Psychopharmacol Bull 20:39–40
Kennedy PF, Hershon HJ, McGuire RJ (1971) Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry 118:509–518
Kidger T, Barnes RE, Trauer T, Taylor PJ (1980) Sub-syndromes of tardive dyskinesia. Psychol Med 10:513–520
Klawans HL (1983) Symposium on tardive dyskinesia. Clin Neuropharmacol 6:75–168
Klawans HL, Goetz CG, Perlik S (1980) Tardive dyskinesia. Review and update. Am J Psychiatry 137:900–908
Kraepelin E (1913) Psychiatrie, 8. Aufl. Barth, Leipzig
Levine J, Schooler NR, Severe J et al. (1980) Discontinuation of oral and depotfluphenazine in schizophrenic patients after one year of continuous medication. Adv Biochem Psychopharmacol 22:483–493
Lieberman J, Kane JM, Woerner M, Weinhold P, Basavaraju N, Kurucz J, Bergmann K (1984) Prevalence of tardive dyskinesia in elderly samples. Psychopharmacol Bull 20:382–386
Mallya A, Jose C, Baig M, Williams R, Cho D, Mehta D, Volavka J (1979) Antiparkinsonics, neuroleptics and tardive dyskinesia. Biol Psychiatry 14:645–649
Marsden CD (1985) Is tardive dyskinesia a unique disorder? In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacology, Suppl 2. Springer, Berlin Heidelberg New York Tokyo
Marsden CD,Tarsy D, Baldessarini RJ (1975) Spontaneous and drug-induced movement disorders in psychotic patients. In: Benson DF, Blumer D (eds) Psychiatric aspects of neurologic disease. Grune & Stratton, New York
Munetz MR, Cornes CL (1982) Akathisia, pseudoakathisia and tardive dyskinesia: Clinical examples. Compr Psychiatry 23:345–348
Nasrallah HA (1980) Neuroleptic plasma levels and tardive dyskinesia: A possible link? Schizophr Bull 6:4–7
Owens DGC, Johnstone EC, Frith CD (1982) Spontaneous involuntary disorders of move ment in neuroleptic treated and untreated chronic schizophrenics. Arch Gen Psychiatry 39:452–461
Owens DGC, Johnstone EC, Crow DJ, Frith CD, Jagon JR, Kreel L (1985) Lateral ventricular size in schizophrenia: Relationship to the disease process and its clinical manifestations. Psychol Med 15:27–41
Richardson MA, Craig TJ (1982) The coexistence of parkinsonismlike symptoms and tardive dyskinesia. Am J Psychiatry 139:341–343
Rosen AM, Mukherjee S, Olarte S, Varia V, Cardenas C (1982) Perception of tardive dyskinesia in outpatients receiving maintenance neuroleptics. Am J Psychiatry 139:372–373
Rosenbaum KM, Niven RG, Hanson NP, Swanson DW (1977) Tardive dyskinesia: Relationship with primary affective disorder. Dis Nerv Syst 38:423–427
Rüther E, Bindig R, Ther P (1978) Neuropharmakotherapie dyskinetischer Syndrome. Pharmakotherapie 1:200–210
Rüther E, Haag M, Oefele K von, Kettler E, Haag H (1987) Späte extrapyramidale Hyperkinesen (Spätdyskinesien): Risiko der Neurolepsie? In: Pichot P, Möller HJ (Hrsg) Neuroleptika Rückschau 1952–1986. Künftige Entwicklungen. Springer, Berlin Heidelberg New York Tokyo
Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:86–87
SeelerW, Kulhanek F (1980) Späte extrapyramidale Hyperkinesen. Schwarzeck, München
Simpson GM, Lee JH, Zoubak B, Gardos G (1979) A rating scale for tardive dyskinesia. Psychopharmacology 64:171–179
Smith JM, Baldessarini RJ (1980) Changes in prevalence, severity and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 37:1368–1373
Smith JM, Kucharski LT, Eblen C, Knutsen E, Linn C (1979) An assessment of tardive dyskinesia in schizophrenic outpatients. Psychopharmacology 64:99–104
Sprague RL, Kalachnik JE, Breuning SE et al. (1984) The dyskinesia identification system -Coldwater (Dis-Co): A tardive dyskinesia rating scale for the developmentally disabled. Psychopharmacol Bull 20:318–338
Struve FA, Willner AE (1983) Cognitive dysfunction and tardive dyskinesia. Br J Psychiatry 143:597–600
Task Force Report (1980) Task Force on the late neurological effects of antipsychotic drugs: Tardive dyskinesia: Summary of a Task Force Report of the American Psychiatric Association. Am J Psychiatry 137:1163–1172
Tegeler J (1987 a) Depot-Neuroleptika und späte extrapyramidale Hyperkinesen. In: Heinrich K, Sieberns S (Hrsg) Internationales Fluanxol-Depot-Symposium. Das Ärztliche Gespräch. pmi-Verlag, Frankfurt
Tegeler J (1987 b) Nutzen und Risiken der neuroleptischen Langzeitmedikation schizophrener Erkrankungen. In: Kretschmar C (Hrsg) Fragen zur Schizophrenie. Organon, München
Tegeler J, Wöller W (1983) Therapeutische Maßnahmen bei späten extrapyramidalen Hyperkinesen. Fortschr Neurol Psychiat 51:203–226
Tegeler J, Bogerts B,Wurthmann C (1988a) CT-Untersuchungen an schizophrenen Patienten mit späten Hyperkinesen. In: Beckmann H, Laux D (Hrsg) Biologische Psychiatrie. Springer, Berlin Heidelberg New York Tokyo
Tegeler J, Strauss WH, Lüthcke H, Bertling R (1988 b) Cognitive functions in schizophrenic patients with tardive dyskinesia. Pharmacopsychiatria 21:308–309
Tepper S, Haas J (1979) Prevalence of tardive dyskinesia. J Clin Psychiatry 40:508–516
Toenniessen LM, Casey DE, McFarland BH (1985) Tardive dyskinesia in the aged. Arch Gen Psychiatry 42:278–284
Villeneuve A (1972) The rabbit-syndrome: A peculiar extrapyramidal reaction. Can Psychiatr Ass J (Suppl 2) 17:69–72
Waddington JL, Youssef HA, Molloy AG, O’Boyle KM, Pugh MT (1985) Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: Clinical and animal studies. J Clin Psychiatry 46:29–33
Wegner JT, Kane JM, Weinhold P, Woerner M, Kinon B, Lieberman J (1985) Cognitive impairment in tardive dyskinesia. Psychiat Res 16:331–337
Weiner WJ, Goetz CG, Nausieda PA, Klawans HL (1978) Respiratory dyskinesias: ex trapyramidal dysfunction and dyspnea. Ann Int Med 88:327–331
Williams AO, Reveley MA, Kolakowska T, Ardern M, Mandelbrote BM (1985) Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance. Br J Psychiatry 146:239–246
Wöller W, Tegeler J (1983) Späte extrapyramidale Hyperkinesen, Klinik -Prävalenz Pathophysiologie. Fortschr Neurol Psychiat 51:131–157
Yassa R, Nair V, Dimitry R (1986) Prevalence of tardive dystonia. Acta Psychiat Scand 73:629–633
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Tegeler, J. (1989). Klinik der Spätdyskinesien. In: Hippius, H., Rüther, E., Schmauss, M. (eds) Katatone und dyskinetische Syndrome. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83654-1_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-83654-1_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50501-3
Online ISBN: 978-3-642-83654-1
eBook Packages: Springer Book Archive